Stock listing

Devyser Diagnostics Ab

Selected listing: DVYSR · OMXSTO · SEK · SE

Devyser Diagnostics Ab (Stockholm:DVYSR), Health Technology. Latest release Apr 27, 2026: Devyser Diagnostics AB publishes quarterly report for the period…

DVYSR:OMXSTOSEKSEUpdated October 3, 2026

Ticker: Stockholm:DVYSR
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: Stockholm
Currency: SEK

About Devyser Diagnostics Ab

Devyser Diagnostics Ab is a public company listed under the ticker DVYSR on the Swedish market. Devyser specializes in the development of innovative diagnostic solutions for genetic testing.

Latest news from Devyser Diagnostics Ab

Devyser Diagnostics AB publishes quarterly report for the period January to March 2026

April 27, 2026

Devyser announces that Chief Commercial Officer will leave the company

April 7, 2026

Devyser completes acquisition of CyberGene AB and carries out issue of compensation shares

April 1, 2026

Devyser Diagnostics AB publishes year-end report for January to December 2025

February 12, 2026

Devyser acquires Swedish company Cybergene AB and strengthens its position in the aneuploidy market

February 11, 2026

All Devyser Diagnostics Ab news →

Events

Replays

Devyser Diagnostics AB (publ) (DVYSR) Q2 2026 Earnings Call
Mon, Jul 20, 2026 · 03:00 AM ET
Watch
Devyser Diagnostics AB (publ) (DVYSR) Q1 2026 Earnings Call
Mon, Apr 27, 2026 · 03:00 AM ET
Watch
Devyser Diagnostics AB (publ) (DVYSR) Q4 2025 Earnings Call
Thu, Feb 12, 2026 · 03:00 AM ET
Watch

Research Devyser Diagnostics Ab

Devyser Diagnostics Ab company profile

View the public company page for Devyser Diagnostics Ab on 6ix.

Devyser Diagnostics Ab news

Read company news and market updates connected to Devyser Diagnostics Ab.

Devyser Diagnostics Ab investor events

Find investor webinars, events, and replay context for Devyser Diagnostics Ab.